EMV Capital plc
("EMV Capital" or
the "Company")
Director/PDMR
Shareholding
EMV Capital plc (AIM: EMVC), the
deeptech and life sciences VC investment group, announces that on 2
October 2024, Dr Jonathan Robinson (Senior Independent Director)
purchased 25,000 ordinary shares in the capital of EMV Capital plc
("Ordinary
Shares") through
his Self-Invested Personal Pension.
Following such purchase, Dr Robinson
is interested in 199,253 Ordinary Shares, representing 0.82 per
cent. of the entire issued share capital of the Company.
The information below, set out in
accordance with the requirements of the UK Market Abuse
Regulation, provides further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
|
1
|
Details of the
person discharging managerial responsibilities / person closely
associated
|
|
a)
|
Name
|
Dr Jonathan Robinson
|
|
2
|
Reason for the
notification
|
|
a)
|
Position/status
|
Director
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the
issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
|
a)
|
Name
|
EMV Capital plc
|
|
b)
|
LEI
|
213800N5WD46G1Y7I458
|
|
4
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
EMVC 5p Ordinary Shares
GB00BN4R5Q82
|
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares into SIPP
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
£0.52
|
25,000 shares
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
|
Price
|
Volume
|
|
£0.52
|
25,000 shares
|
|
|
e)
|
Date of the transaction
|
2 October 2024
|
|
f)
|
Place of the transaction
|
UK AIM
|
# #
#
|
For
more information, please contact:
|
|
EMV
Capital plc
|
via Rosewood
|
|
Ilian Iliev, CEO
|
|
|
|
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker)
|
+44 (0)20 7886 2500
|
|
Emma Earl / Will Goode / Freddy
Crossley / Mark Rogers (Corporate Finance)
|
|
|
Rupert Dearden (Corporate
Broking)
|
|
|
|
|
|
Rosewood (Financial
PR)
|
+44 (0)20 7653 8702
|
|
John West / Llewellyn Angus / Lily Pearce
|
|
About EMV
Capital plc (EMVC)
EMV Capital plc, formerly known as
NetScientific plc, is a deep tech and life sciences venture capital
investment group with an international portfolio of high-growth
companies.
With a strategic focus on generating superior
returns for investors from the fast-growing sectors and
technologies that will define our future; EMV Capital invests in,
manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity stakes and
carried interest in its portfolio companies, creating an evergreen
structure that supports extensive growth and value creation. EMV
Capital's investment thesis is realised through these capital
sources:
·
capital-efficient investments through Group balance
sheet;
·
fund management of the Evergreen EIS and Martlet Capital
Funds;
·
syndicated investments leveraging its network of third-party
investors.
EMV Capital's approach is characterised by its
proactive management style, aiming to advance portfolio companies
to critical value inflection points by actively engaging with them.
Companies are supported through Board representation and the use of
its Value Creation Services practice.
Headquartered in London, with a Cambridge
presence and strong international links, EMV Capital is quoted on
the AIM market of the London Stock Exchange.
www.emvcapital.com